The workplace project – putting learning into practice

Taking practical education to a fundamental level, every two-module MasterClass includes an intermodule project as a mandatory part of the course. An opportunity to test new knowledge and skills and to improve local services, delegates are offered mentorship and encouraged to support their peers as they continue to develop their specialism in a way that directly impacts their patient's outcomes.

Attendees have free reign over this project. It might be service delivery, patient management or drug treatments, and it could take the form of a service description, an audit, or another form of research. It should meet a local need.

When complete, the project closes with a presentation to the other course members, faculty, and often their managers, commissioners or other people of influence in their area. The group chooses a winner and runner up who receive an award at an evening event.

Showing projects in the MS Academy

You can also view projects in...

Neuropharmacy Academy Parkinson's Academy Dementia Academy

Featured projects in Medication

Early monitoring of B cells on Ocrelizumab may help to identify those at risk of adverse effects
By Chandni Radia, Lead Pharmacist Neurosciences, Imperial College Healthcare NHS Trust  in  Medication
Time from ‘treatment decision’ to ‘actual start of DMT’ in MS – a local clinical survey
By Dr Bindu Yoga, Consultant Neurologist, Mid Yorkshire Hospitals NHS Trust  in  Medication
Audit of safe monitoring of MS patients on natalizumab
By Dr Lewis Kass-lliyya, Dr Jennifer Hosty and Dr Simon Bell, Royal Hallamshire Hospital (Supervisor: Dr David Paling)  in  Medication
Audit of disease modifying treatments of multiple sclerosis at Royal Preston Hospital
By Dr Farhat Mirza, SpR in Neurology, Royal Preston Hospital  in  Medication
Fingolimod safety considerations in real-world practice: fingolimod-associated macular oedema (FAME)
By Dr Paul Gallagher and Dr Sarah-Jane Martin, Institute of Neurological Sciences, Glasgow  in  Medication
Listeriosis prevention in alemtuzumab treated patients
By Dr Rachelle Shafei, Clinical Research Fellow, University College London  in  Medication
JCV in Jersey
By Dr Jessica Vaz, Associate Specialist, Jersey General Hospital  in  Medication